In a historic milestone for the pharmaceutical industry, Eli Lilly surged to a market value of $1 trillion on Friday. It became the first drugmaker to join an exclusive club previously dominated by technology heavyweights. This event marked the moment Lilly hit a $1 trillion valuation. It highlighted the company’s rapid ascent as a global powerhouse in the weight-loss sector.…